NCT05119387 (GAIN) is a clinical trial of Observation in Amyotrophic Lateral Sclerosis, sponsored by Sykehuset Telemark.

Who is sponsoring NCT05119387?

NCT05119387 is sponsored by Sykehuset Telemark.

What drugs are being tested in NCT05119387?

Interventions in NCT05119387: Observation.

What condition does NCT05119387 study?

NCT05119387 studies Amyotrophic Lateral Sclerosis.

Is NCT05119387 still recruiting?

NCT05119387 is currently recruiting now. Last updated 8 January 2025.

Last reviewed 2025-01-08 · How we verify

NCT05119387: GAIN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Genetic Study of Amyotrophic Lateral Sclerosis in Norway

Recruiting now Last updated 8 January 2025

What this trial tests

trial testing Observation in Amyotrophic Lateral Sclerosis in 1,200 participants. Currently enrolling.

Timeline

1 August 2019

Primary endpoint
31 December 2030

31 December 2035

Quick facts

Lead sponsor	Sykehuset Telemark
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	1,200
Start date	1 August 2019
Primary completion	31 December 2030
Estimated completion	31 December 2035
Sites	17 locations across Norway

Drugs / interventions tested

Observation

Conditions studied

Amyotrophic Lateral Sclerosis — all drugs for Amyotrophic Lateral Sclerosis →

Sponsor

Sykehuset Telemark — full company profile →

Who can join

Adults 16 to 100, any sex, with Amyotrophic Lateral Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Observation

Trials testing the same drug.

NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
NCT07563088 — SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · not yet recruiting
NCT07513324 — Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · Phase 2 · not yet recruiting
NCT07457099 — Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral a · not yet recruiting
NCT07472478 — Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12 · Phase 2 · not yet recruiting

Other recruiting trials for Amyotrophic Lateral Sclerosis

Currently open trials in the same condition.

NCT07502677 — Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Scle · recruiting
NCT07478172 — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease · NA · recruiting
NCT07204977 — Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS) · Phase 1 · active not recruiting
NCT07290062 — A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants · Phase 1 · recruiting
NCT07259980 — A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD- · recruiting

Other Sykehuset Telemark trials

Trials by the same sponsor.

NCT06724198 — Bowel Dysfunction After Low Rectal Resection. An Pilot Study Using Psyllium Husk In Rectal Cancer Patients. · NA · active not recruiting
NCT05227729 — Descending Aorta Blood Flow to Guide Fluid Therapy During Surgery · completed
NCT04763720 — Implementing Dyadic Developmental Psychotherapy (DDP) - Evaluation Research · enrolling by invitation
NCT05138055 — The NOrwegian Tick-borne Encephalitis Study · active not recruiting
NCT04514003 — The Corona and COVID-19 Study in Telemark and Agder · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05119387 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sykehuset Telemark
Last refreshed: 8 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05119387.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing